What is the diagnosis and treatment for a rash with petechiae on the sternum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Petechial Rash on Sternum: Diagnosis and Management

Immediate Clinical Action

Empiric doxycycline therapy must be initiated immediately if Rocky Mountain Spotted Fever (RMSF) is suspected, as 50% of deaths occur within 9 days of illness onset and delay in treatment significantly increases mortality. 1

Critical Differential Diagnosis

The presence of petechiae on the sternum demands urgent evaluation for life-threatening conditions:

Life-Threatening Infectious Causes (Highest Priority)

  • Rocky Mountain Spotted Fever (RMSF): The classic petechial rash appears by day 5-6 of illness, beginning as small blanching pink macules on ankles, wrists, or forearms that evolve to maculopapular lesions with central petechiae, though up to 20% of cases may lack rash entirely. 2 Absence of rash is associated with increased mortality. 2

  • Meningococcemia (Neisseria meningitidis): Causes invasive disease with petechial or purpuric rash that can rapidly progress to purpura fulminans, typically appearing alongside high fever, severe headache, and altered mental status. 2 Up to 50% of early meningococcal cases lack rash initially. 2

  • Bacterial endocarditis: Petechiae can occur with bacterial endocarditis and should be considered in patients with cardiac risk factors. 2

Viral Causes (Common, Usually Benign)

  • Parvovirus B19: During outbreaks, parvovirus was confirmed in 76% of children with petechial rash, typically presenting with mild constitutional symptoms, fever (85% of cases), dense and widely distributed petechiae, leukopenia, and occasionally thrombocytopenia. 3 Viral infections were identified in 67% of pediatric cases with petechial rash. 4

  • Other viral pathogens: Human herpesvirus 6 (roseola), Epstein-Barr virus, enteroviruses, and respiratory viruses may present with maculopapular rashes that include petechial components. 2

Autoimmune/Vasculitic Causes

  • Rheumatoid arthritis and Adult-Onset Still's Disease: Can present with vasculitic purpuric rash, sometimes associated with mixed cryoglobulinemia. 5

Hematologic Causes

  • Thrombotic thrombocytopenic purpura (TTP): Can cause petechial rash alongside systemic manifestations. 2

Drug-Induced and Mechanical Causes

  • Drug hypersensitivity reactions can cause petechial rash. 2
  • Trauma causing increased capillary pressure (tourniquet phenomenon) can result in localized petechiae. 2, 6

Diagnostic Approach

Immediate Assessment

Look for these specific clinical features:

  • Fever, headache, myalgias: Suggest RMSF or meningococcemia. 1
  • Tick exposure history: Present in only 60% of RMSF cases, so absence does not exclude diagnosis. 1
  • Rash distribution: Involvement of palms and soles indicates advanced RMSF disease and is associated with severe illness. 2 Localized petechiae (especially lower limbs) in well-appearing patients suggest benign etiology. 6
  • Systemic toxicity: Fever, tachycardia, confusion, hypotension, or altered mental status indicate life-threatening infection. 1
  • Progression: Rapidly spreading petechiae or development of purpura suggests meningococcemia or necrotizing infection. 1

Laboratory Evaluation

  • Complete blood count: Assess for thrombocytopenia, leukopenia (common in viral causes), or leukocytosis (bacterial causes). 1, 3
  • Coagulation profile: Evaluate for DIC if systemic toxicity present. 1
  • Blood cultures: Positive in only 5% of cellulitis cases but critical for endocarditis and sepsis. 1
  • Inflammatory markers: AST, ALT elevations seen in severe RMSF. 1
  • Serology: IgM and IgG antibodies for RMSF are typically not detectable before the second week of illness, making early serology unhelpful. 1
  • PCR testing: R. rickettsii DNA can be detected in serum when serology is negative. 1 Viral PCR from nasopharyngeal aspirates can rapidly identify viral pathogens. 4

Treatment Algorithm

If Systemic Toxicity or Suspected RMSF/Meningococcemia:

Start empiric doxycycline immediately—do not wait for confirmatory testing. 1 The majority of broad-spectrum antimicrobials, including penicillins, cephalosporins, aminoglycosides, erythromycin, and sulfa-containing drugs are not effective against rickettsiae. 1

  • Doxycycline dosing: Standard dosing for RMSF (specific dosing per institutional protocols). 1
  • Add ceftriaxone: If meningococcemia cannot be excluded. 1
  • Hospitalization: Required for systemic toxicity, rapidly progressive rash, or diagnostic uncertainty. 1

If Well-Appearing Patient with Localized Petechiae:

  • Observation period: 4 hours of observation to assess for progression of signs. 6
  • Discharge criteria: No fever, no systemic symptoms, no progression of petechiae, normal or mildly abnormal blood counts. 6
  • Follow-up: Return immediately if fever develops, rash spreads, or systemic symptoms appear. 7

If Viral Etiology Confirmed:

  • Supportive care only. 3, 4
  • Most cases are brief and uncomplicated. 3

Critical Pitfalls to Avoid

  • Do not wait for the classic triad: Fever, rash, and tick bite in RMSF is present in only a minority of patients at initial presentation. 2
  • Do not exclude serious disease based on absence of rash: Up to 20% of RMSF cases and 50% of early meningococcal cases lack rash. 2
  • Do not assume location is pathognomonic: Rash on sternum (or palms/soles) is not specific—consider RMSF, meningococcemia, secondary syphilis, endocarditis, and drug reactions. 2
  • Do not miss rash in darker-skinned patients: Petechial rashes may be difficult to recognize, increasing risk of delayed diagnosis. 2
  • Do not over-investigate well-appearing patients: Extensive tests and antibiotic treatment in well children with localized petechiae may not be necessary and have potential to cause harm. 7, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Blanching Petechial Rash Causes and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Petechial Rash in Rheumatoid Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Petechiae/purpura in well-appearing infants.

Pediatric emergency care, 2012

Research

Diagnostic and treatment dilemmas in well children with petechial rash in the emergency department.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.